Power supply
Chapter 4 examines the development and the suitability of polymeric micelle based formulations of corticosteroids – triamcinolone acetonice (TA) and fluocinonide (FLU) using d-ɑ-tocopheryl
poly(ethylene glycol) 1000 succinate for the treatment of oral lichen planus. The objectives of the study were to provide a patient friendly and therapeutically relevant formulation of the drug. Micellar
27
hydrogel were formulated and the delivery of the drugs was compared to the commercial marketed formulations of the drugs at the target site after a short-term application.
28 References
1. Oral Mucosa. https://pocketdentistry.com/12-oral-mucosa/
2. Groeger S. and Meyle J. Oral Mucosal Epithelial Cells. Front Immunol. 2019 10: 208-208.
3. Qin R., Steel A. et al. Oral mucosa biology and salivary biomarkers. Clinics in Dermatology. 2017 35(5): 477-483.
4. Hearnden V., Sankar V. et al. New developments and opportunities in oral mucosal drug delivery for local and systemic disease. Adv. Drug Deliv. Rev. 2012 64(1): 16-28.
5. Squier C. A. Membrane coating granules in nonkeratinizing oral epithelium. Journal of Ultrastructure Research. 1977 60(2): 212-220.
6. Hill M. W., Squier C. A. et al. A histological method for the visualization of the intercellular permeability barrier in mammalian stratified squamous epithelia. The Histochemical journal. 1982 14(4): 641-8.
7. Bergmeier L., Oral Mucosa in Health and Disease. ed.; Springer International Publishing, 2018.
8. Dawson D. V., Drake D. R. et al. Organization, barrier function and antimicrobial lipids of the oral mucosa.
International journal of cosmetic science. 2013 35(3): 220-3.
9. Iorgulescu G. Saliva between normal and pathological. Important factors in determining systemic and oral health. J Med Life. 2009 2(3): 303-307.
10. Wanasathop A. and Li S. K. Iontophoretic Drug Delivery in the Oral Cavity. Pharmaceutics. 2018 10(3).
11. Singhal M., Merino V. et al. Controlled Iontophoretic Delivery in Vitro and in Vivo of ARN14140—A Multitarget Compound for Alzheimer’s Disease. Mol. Pharm. 2019 16(8): 3460-3468.
12. Kalaria D. R., Patel P. et al. Controlled iontophoretic transport of huperzine A across skin in vitro and in vivo:
effect of delivery conditions and comparison of pharmacokinetic models. Mol. Pharm. 2013 10(11): 4322-9.
13. Santer V., Chen Y. et al. Controlled non-invasive iontophoretic delivery of triamcinolone acetonide amino acid ester prodrugs into the posterior segment of the eye. Eur. J. Pharm. Biopharm. 2018 132: 157-167.
14. Telo I., Tratta E. et al. In-vitro characterization of buccal iontophoresis: the case of sumatriptan succinate. Int.
J. Pharm. (Amsterdam, Neth.). 2016 506(1-2): 420-8.
15. Kalia Y. N., Naik A. et al. Iontophoretic drug delivery. Adv. Drug Deliv. Rev. 2004 56(5): 619-658.
16. Pikal M. J. The role of electroosmotic flow in transdermal iontophoresis. Adv. Drug Deliv. Rev. 1992 9(2):
201-237.
17. Nicoli S., Ferrari G. et al. In vitro transscleral iontophoresis of high molecular weight neutral compounds.
Eur. J. Pharm. Sci. 2009 36(4-5): 486-92.
18. Smart J. D. Buccal drug delivery. Expert Opin. Drug Deliv. 2005 2(3): 507-17.
19. Cubayachi C., Couto R. O. et al. Needle-free buccal anesthesia using iontophoresis and amino amide salts combined in a mucoadhesive formulation. Colloids Surf. B Biointerfaces. 2015 136: 1193-201.
29
20. De Caro V., Giandalia G. et al. New prospective in treatment of Parkinson's disease: studies on permeation of ropinirole through buccal mucosa. Int. J. Pharm. (Amsterdam, Neth.). 2012 429(1-2): 78-83.
21. Wei R., Simon L. et al. Effects of iontophoresis and chemical enhancers on the transport of lidocaine and nicotine across the oral mucosa. Pharm. Res. 2012 29(4): 961-71.
22. Campisi G., Giannola L. I. et al. Bioavailability in vivo of naltrexone following transbuccal administration by an electronically-controlled intraoral device: a trial on pigs. J. Control. Release. 2010 145(3): 214-20.
23. Jacobsen J. Buccal iontophoretic delivery of atenolol.HCl employing a new in vitro three-chamber permeation cell. J. Control. Release. 2001 70(1-2): 83-95.
24. Hu L., Damaj B. B. et al. Enhanced in vitro transbuccal drug delivery of ondansetron HCl. Int. J. Pharm.
(Amsterdam, Neth.). 2011 404(1-2): 66-74.
25. Oh D. H., Chun K. H. et al. Enhanced transbuccal salmon calcitonin (sCT) delivery: effect of chemical enhancers and electrical assistance on in vitro sCT buccal permeation. Eur. J. Pharm. Biopharm. 2011 79(2): 357-63.
26. Patel M. P., Churchman S. T. et al. Electrically induced transport of macromolecules through oral buccal mucosa. Dent Mater. 2013 29(6): 674-81.
27. Paderni C., Campisi G. et al. Controlled delivery of naltrexone by an intraoral device: in vivo study on human subjects. Int. J. Pharm. (Amsterdam, Neth.). 2013 452(1-2): 128-34.
28. Wagner M. J. and Weil T. M. Reduction of enamel acid solubility with electrophoretic fluoride applications.
J. Dent. Res. 1966 45(5): 1563.
29. Kim H. E., Kwon H. K. et al. Application of fluoride iontophoresis to improve remineralization. J Oral Rehabil. 2009 36(10): 770-5.
30. Kim H. E. and Kim B. I. Can the Application of Fluoride Iontophoresis Improve Remineralisation of Early Caries Lesions? Oral health & preventive dentistry. 2016 14(2): 177-82.
31. Lee Y. E., Baek H. J. et al. Comparison of remineralization effect of three topical fluoride regimens on enamel initial carious lesions. J Dent. 2010 38(2): 166-71.
32. Patil A. R., Varma S. et al. Comparative Evaluation of Efficacy of Iontophoresis with 0.33% Sodium Fluoride Gel and Diode Laser Alone on Occlusion of Dentinal Tubules. Journal of clinical and diagnostic research : JCDR. 2017 11(8): Zc123-zc126.
33. Gupta M., Pandit I. K. et al. Comparative evaluation of 2% sodium fluoride iontophoresis and other cavity liners beneath silver amalgam restorations. Journal of the Indian Society of Pedodontics and Preventive Dentistry.
2010 28(2): 68-72.
34. Smitayothin T. L., Vongsavan K. et al. The iontophoresis of lignocaine with epinephrine into carious dentine for pain control during cavity preparation in human molars. Arch. Oral Biol. 2015 60(8): 1104-8.
35. Thongkukiatkun W., Vongsavan K. et al. Effects of the iontophoresis of lignocaine with epinephrine into exposed dentine on the sensitivity of the dentine in man. Arch Oral Biol. 2015 60(8): 1098-103.
36. Torchilin V. P. Structure and design of polymeric surfactant-based drug delivery systems. J. Control. Release.
2001 73(2): 137-172.
30
37. Lapteva M., Möller M. et al., Polymeric Micelles in Dermal and Transdermal Delivery. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement: Nanocarriers, ed.; Dragicevic, N.;
Maibach, H. I., Springer Berlin Heidelberg, Berlin, Heidelberg, 2016.
38. Lapteva M., Mignot M. et al. Self-assembled mPEG-hexPLA polymeric nanocarriers for the targeted cutaneous delivery of imiquimod. Eur. J. Pharm. Biopharm. 2019.
39. Lapteva M., Möller M. et al. Self-assembled polymeric nanocarriers for the targeted delivery of retinoic acid to the hair follicle. Nanoscale. 2015 7(44): 18651-18662.
40. Lapteva M., Mondon K. et al. Polymeric Micelle Nanocarriers for the Cutaneous Delivery of Tacrolimus: A Targeted Approach for the Treatment of Psoriasis. Mol. Pharm. 2014 11(9): 2989-3001.
41. Kandekar S. G., Del Rio-Sancho S. et al. Selective delivery of adapalene to the human hair follicle under finite dose conditions using polymeric micelle nanocarriers. Nanoscale. 2018 10(3): 1099-1110.
42. Lv Q., Shen C. et al. Mucoadhesive buccal films containing phospholipid-bile salts-mixed micelles as an effective carrier for Cucurbitacin B delivery. Drug delivery. 2015 22(3): 351-358.
43. Zhou L., Zhang P. et al. Preparation, characterization, and evaluation of amphotericin B-loaded MPEG-PCL-g-PEI micelles for local treatment of oral Candida albicans. International journal of nanomedicine. 2017 12:
4269-4283.
44. Suksiriworapong J., Mingkwan T. et al. Enhanced transmucosal delivery of itraconazole by thiolated d-a-tocopheryl poly(ethylene glycol) 1000 succinate micelles for the treatment of Candida albicans. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 2017 120: 107-115.
CHAPTER I
A targeted approach to treat oral submucous fibrosis
33